Assetmark Inc. cut its holdings in Nova Ltd. (NASDAQ:NVMI – Free Report) by 8.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,808 shares of the semiconductor company’s stock after selling 3,575 shares during the quarter. Assetmark Inc. owned 0.12% of Nova worth $16,854,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently bought and sold shares of NVMI. Harel Insurance Investments & Financial Services Ltd. boosted its position in shares of Nova by 47.5% during the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 2,166,073 shares of the semiconductor company’s stock worth $940,683,000 after purchasing an additional 697,210 shares in the last quarter. Invesco Ltd. lifted its stake in shares of Nova by 185.4% in the third quarter. Invesco Ltd. now owns 607,344 shares of the semiconductor company’s stock valued at $194,144,000 after purchasing an additional 394,544 shares during the period. Phoenix Financial Ltd. boosted its holdings in Nova by 286.3% during the fourth quarter. Phoenix Financial Ltd. now owns 508,641 shares of the semiconductor company’s stock worth $167,115,000 after buying an additional 376,974 shares in the last quarter. Norges Bank acquired a new position in Nova during the fourth quarter worth about $109,568,000. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new position in Nova in the fourth quarter valued at about $56,158,000. Institutional investors and hedge funds own 82.99% of the company’s stock.
Nova Price Performance
Shares of Nova stock opened at $437.46 on Monday. Nova Ltd. has a fifty-two week low of $232.73 and a fifty-two week high of $615.99. The business’s fifty day moving average is $508.39 and its two-hundred day moving average is $473.16. The firm has a market cap of $13.90 billion, a PE ratio of 54.55, a P/E/G ratio of 3.17 and a beta of 1.74.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on the company. Citigroup lifted their price objective on Nova from $520.00 to $595.00 and gave the stock a “buy” rating in a report on Friday, May 15th. Barclays upped their target price on shares of Nova from $465.00 to $600.00 and gave the company an “overweight” rating in a report on Friday, May 15th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $600.00 price target on shares of Nova in a research note on Tuesday, July 14th. Zacks Research downgraded shares of Nova from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 14th. Finally, Wall Street Zen raised shares of Nova from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Eight research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $556.67.
Get Our Latest Analysis on NVMI
Insiders Place Their Bets
In other news, Director Yaniv Garty sold 366 shares of the stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $581.20, for a total transaction of $212,719.20. Following the transaction, the director directly owned 2,006 shares in the company, valued at $1,165,887.20. This represents a 15.43% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Sarit Sagiv sold 454 shares of the firm’s stock in a transaction that occurred on Tuesday, June 23rd. The stock was sold at an average price of $536.52, for a total transaction of $243,580.08. Following the completion of the sale, the director directly owned 1,951 shares in the company, valued at $1,046,750.52. This represents a 18.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,798 shares of company stock worth $4,125,266 over the last 90 days. Corporate insiders own 1.00% of the company’s stock.
About Nova
Nova Measuring Instruments Ltd (NASDAQ: NVMI) develops and supplies advanced metrology and process control systems for the semiconductor manufacturing industry. The company’s core product line includes spectroscopic ellipsometry and scatterometry tools designed to measure film thickness, critical dimensions, overlay alignment and other key parameters that drive yield and performance in integrated circuit fabrication.
Founded in 1993 and headquartered in Rehovot, Israel, Nova Measuring Instruments has established itself as a critical partner to leading semiconductor foundries and device manufacturers.
Recommended Stories
- Five stocks we like better than Nova
- Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
- Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet
- Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises
- 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks
Receive News & Ratings for Nova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nova and related companies with MarketBeat.com's FREE daily email newsletter.
